ACLX Stock Analysis: Buy, Sell, or Hold?
ACLX - Arcellx, Inc. Common Stock
$114.57
-0.05 (-0.04%)
▼
5d:
-0.17%
30d:
+0.61%
90d:
+73.01%
BUY
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Distribution
ACLX is up 77.5% this week, but smart money is buying puts. Top strike: $80 2026-04-17 with 1,520 OI. Put ratio: 71% View Scanner →
Strength: 10.0/10
Get Alerted When ACLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ACLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ACLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ACLX is currently trading at $114.57, which is considered fair relative to its 30-day fair value range of $91.67 to $124.02.
Technical Outlook: Technically, ACLX is in a strong uptrend. The price is currently testing key support at $114.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACLX is in a strong uptrend. The price is currently testing key support at $114.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$91.67 -
$124.02
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
ACLX is technically overbought (RSI 82). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($111.07)
Fair Price Analysis
30-Day Fair Range
$91.67 -
$124.02
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$114.30
Resistance Level
$114.91
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-66.21
Wall Street Target
$111.07
(-3.1%)
Revenue Growth (YoY)
-89.2%
Share & Embed Analysis
Last updated: March 30, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Rami Elghandour
SELL
89916 shares
2026-02-27
Christopher Heery
SELL
5882 shares
2026-01-14
Christopher Heery
SELL
7437 shares
2026-01-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 60 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 59 HOLD |
Advanced ACLX Option Strategies
Professional options setups generated by AI based on today's ACLX price and gamma walls.
